BA.5 variant detected in the Netherlands The BA.5 variant of the coronavirus SARS-CoV-2 was detected for the first time in the Netherlands this week.
People with impaired immunity invited for repeat vaccination From 19 April on, people who have moderately or severely impaired immunity will receive their invitation for a repeat vaccination against COVID-19.
Most reports received by MEBI in 2021 concerned copper IUDs More reports of suspected adverse effects from copper intrauterine devices (IUDs) were made in 2021 than in previous years, according to the annual report of the Dutch reporting and expertise centre for adverse effects of medical implants (MEBI).
RIVM recalls fill needles for COVID-19 vaccination at supplier’s request As of today, RIVM is recalling the fill needles made by MLS/Sol-Millenium Europe as a precaution, following a safety alert from the supplier. This applies to the SOL-M™ Blunt Fill Needle (REF 110022, LOT 05103013).
Collaboration necessary to ensure the safe reuse of consumer products In a circular economy, products, materials and raw materials are continually reused. For example, consumer products like clothes, packaging and toys.
Global Infectious Disease Control hampered by the CBD Nagoya Protocol So far, none of the models used by international networks of biobanks to arrange the legal responsibility under the CBD-Nagoya protocol works efficiently.
Tuberculosis in the spotlights A large international congress on tuberculosis will start in The Hague on October 24.
RIVM visits German Environment Agency (UBA) On 17 and 18 October 2018, RIVM visited the German Environment Agency Umwelt Bundesamt (UBA).
The introduction of the colorectal cancer screening programme in the Netherlands In 2014, a colorectal cancer screening programme was launched in the Netherlands. In a factsheet we describe the lessons learned during the introduction of this nationwide programme.
Sustainability Day at RIVM: Microplastics Today, 10 October 2018, is national Sustainability Day in the Netherlands.